about
Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cellsAlternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.The impact of microRNAs on the regulation of tissue factor biology.Regulation of vascular function on posttranscriptional level.The role of tissue factor isoforms in cancer biology.The impact of α-Lipoic acid on cell viability and expression of nephrin and ZNF580 in normal human podocytes.Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.Tissue Factor: A Conventional or Alternative Target in Cancer Therapy.Update on the protective renal effects of metformin in diabetic nephropathy.Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes.Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator.Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel.Comparative analysis of the complete genome sequence of the plant growth-promoting bacterium Bacillus amyloliquefaciens FZB42.CCN1: a novel inflammation-regulated biphasic immune cell migration modulator.Leptin and resistin induce increased procoagulability in diabetes mellitus.Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model.Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.Analysis of the genomic architecture of a complex trait locus in hypertensive rat models links to kidney damageSR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cellsEffects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-alpha-stimulated human endothelial cellsWhat do we know about health risks related to thebaine in food?
P50
Q24321827-DDEC9400-8B2C-47F8-8D92-65B4ACABEF30Q37715189-BCC7E115-CE88-4019-A88D-E9377D89F1D5Q38152116-B52BD363-41E8-4E73-9DEB-22A977A3BFC1Q38167316-B3D7B555-FD31-4023-9272-E2FAA52EB39CQ38210094-19E4F680-0088-4432-956F-818FE1AD82BEQ38729148-55FB41C5-BC27-4F69-803F-73A844878E7FQ38737184-036F21AD-323E-4841-A0E9-31AD63865C2BQ38741745-B8F27BD8-B2A9-49F2-8D8C-DFCC616F36E3Q38844878-5D24023B-992B-49EB-A560-7A3709D63F32Q39162852-92ED433C-DC38-47CA-BA84-2E546BE6DCA3Q39882109-1878D236-49D1-45C1-831C-11D17E074227Q40004766-49D90075-1A32-4435-9DDD-1DFD4E5A9356Q42733455-D9B2A589-237A-4AF0-8414-9140E1CE56A2Q42785173-4927C664-0F61-4242-993A-5C3C37533843Q45930015-5C2485F8-DB1D-4CDE-977C-A96BBD4EC5FFQ46817558-5B810F4B-E89C-437D-9717-85D076524D95Q48078138-D8CC26ED-0EE6-4810-8A8B-77DFC31F3131Q52888605-D1371D12-64EA-433F-BEE8-D215F5259B60Q52894215-DAA2FD8F-6679-4C04-BAA8-9B929834BA41Q52899117-F86CCF70-4D84-49D5-8285-78651967E286Q54331313-CDD5FBE0-F08E-488E-8C3B-E32FA1D644B8Q64060402-BE2D78CB-1704-459B-998B-C59479AC61F3Q80809456-D5526826-62E0-40A1-8215-04AB7D23FB5CQ81801792-BCD57ADA-8413-40FA-8180-91FF88F3EAD6Q91030182-8754D797-6A0E-4788-A42C-CEA413F030B3
P50
description
researcher (ORCID 0000-0002-0615-7901)
@en
name
Andreas Eisenreich
@en
type
label
Andreas Eisenreich
@en
prefLabel
Andreas Eisenreich
@en
P31
P496
0000-0002-0615-7901